Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Margin

    Back to All Ratios
VALIANT LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Margin(%) -4.6210.50

What is the latest Core EBITDA Margin ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Margin ratio of VALIANT LABORATORIES is -4.62 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar2024-4.62
Mar202310.50

How is Core EBITDA Margin of VALIANT LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2024 -4.62
Negative
Mar2023 10.5 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Margin ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹473.2 Cr 0.4% -4.9% -18.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹375,388.0 Cr -2.2% -8.3% -13.1% Stock Analytics
DIVIS LABORATORIES ₹162,513.0 Cr -1.1% -7.3% 21.6% Stock Analytics
CIPLA ₹126,733.0 Cr -0.7% 1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,292.0 Cr -0.5% -4.2% 4.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,935.0 Cr -0.5% -1.1% -7.7% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

0.4%

-4.9%

-18.3%

SENSEX

-1.8%

-1.6%

-2%


You may also like the below Video Courses